Primary Mediastinal B-cell Lymphoma Clinical Trials

22 clinical trials for Primary Mediastinal B-cell Lymphoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) — RECRUITING
• Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU — RECRUITING
• DALY II USA/ MB-CART2019.1 for DLBCL — RECRUITING · PHASE2
• Amping up With PemJAK — RECRUITING · PHASE2
• Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL — RECRUITING · PHASE2
• Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma — RECRUITING · PHASE1
• Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context — RECRUITING
• A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies — NOT_YET_RECRUITING · PHASE1
• Neurocognitive Assessment in Long-Term Survivors of Lymphoma — NOT_YET_RECRUITING
• Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells — ACTIVE_NOT_RECRUITING
• Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy — NOT_YET_RECRUITING
• Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma — ACTIVE_NOT_RECRUITING · NA
• A Phase 1 Study of ADI-001 in B Cell Malignancies — TERMINATED · PHASE1
• ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) — ACTIVE_NOT_RECRUITING · PHASE1
• Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001) — COMPLETED · PHASE1
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma — COMPLETED · PHASE1
• Immune Responses to COVID-19 Vaccination in Lymphoma Patients — COMPLETED
• CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma — COMPLETED · PHASE1
• A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) — COMPLETED · PHASE1
• Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) — COMPLETED · PHASE1
• A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma — COMPLETED
• R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas — COMPLETED · PHASE2

Refine this search